34 completed, 10 active not recruiting, 9 terminated, 5 recruiting. 68 Phase 2, 5 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 68 | Completed 34, Active not recruiting 10, Terminated 9, Recruiting 5, Unknown 5, Withdrawn 5 |
| Phase 1 | 5 | Completed 3, Terminated 2 |
| Phase 3 | 2 | Active not recruiting 1, Unknown 1 |
Follow Leuprolide Acetate: new trials by email Literature Review of Leuprolide Acetate trials Research Report on Leuprolide Acetate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial Abiraterone Acetate, Biospecimen Collection, Leuprolide Acetate - Recurrent Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 | Recruiting | Mayo Clinic | 202 | 2026-08-04 | 2026-09-18 |
| Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma Rezvilutamide, Leuprolide Acetate - Salivary Gland Neoplasm Duct | Phase 2 | Recruiting | Peking University First Hospital | 37 | 2024-10-10 | 2025-09-23 |
| Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors Biospecimen Collection, Chest Radiography, Computed Tomography - Adult Ovarian Granulosa Cell Tumor | Phase 2 | Completed | National Cancer Institute (NCI) | 17 | 2024-02-08 | 2026-11-03 |
| A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer Neoadjuvant treatment - Prostate Cancer | Phase 2 | Withdrawn | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2024-01-01 | 2024-03-18 | |
| Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers Biopsy Procedure, Biospecimen Collection, Computed Tomography - Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 20 | 2023-07-20 | 2026-11-16 |
| Kisspeptin Administration Subcutaneously to Patients With IHH kisspeptin 112-121, leuprolide acetate - Hypogonadotropic Hypogonadism | Phase 2 | Recruiting | Stephanie B. Seminara, MD | 36 | 2023-02-03 | 2026-07-13 |
| RElugolix VErsus LeUprolide Cardiac Trial Radiation therapy, Leuprolide, Relugolix - Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma | Phase 2 | Active not recruiting | Emory University | 94 | 2022-06-06 | 2026-02-12 |
| Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer Leuprolide acetate, Goserelin acetate, Triptorelin acetate - Prostate Cancer | Phase 2 | Unknown | Fudan University | 160 | 2022-04-01 | 2022-03-16 |
| Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer Abiraterone Acetate, Bicalutamide, Degarelix - Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma | Phase 2 | Recruiting | City of Hope Medical Center | 70 | 2021-05-04 | 2026-01-28 |
| Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer Abiraterone Acetate, Apalutamide, Leuprolide Acetate - Metastatic Prostate Adenocarcinoma, Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation | Phase 2 | Active not recruiting | Jonsson Comprehensive Cancer Center | 28 | 2021-03-17 | 2026-02-05 |
| Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study Apalutamide, Degarelix, Leuprolide Acetate - Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2020-11-24 | 2021-01-20 | |
| Neurobiology of Bulimia Nervosa Estradiol, Micronized progesterone, Leuprolide Acetate - Bulimia Nervosa | Phase 2 | Completed | University of North Carolina, Chapel Hill | 10 | 2020-02-24 | 2022-07-26 |
| REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer REGN2810, Degarelix, Leuprolide Acetate - Prostate Cancer Metastatic | Phase 2 | Active not recruiting | Mark Stein | 26 | 2019-05-16 | 2025-04-25 |
| A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery Radiation Therapy, Enzalutamide, Bicalutamide - Prostate Cancer | Phase 2 | Active not recruiting | RTOG Foundation, Inc. | 188 | 2019-04-15 | 2025-12-30 |
| Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer Leuprolide Acetate, Goserelin Acetate, Stereotactic Body Radiation Therapy - Prostate Adenocarcinoma | Phase 2 | Active not recruiting | City of Hope Medical Center | 25 | 2018-08-29 | 2026-04-09 |
| Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery HSV-Tk, Valacyclovir, Bicalutamide - High-risk Prostate Cancer, Prostate Cancer | Phase 2 | Recruiting | The Methodist Hospital Research Institute | 60 | 2018-08-02 | 2021-04-06 |
| A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer Leuprolide Acetate, Prednisone, Docetaxel - Prostate Cancer | Phase 2 | Terminated | Dana-Farber Cancer Institute | 9 | 2017-06-23 | 2020-04-09 |
| Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT Pembrolizumab, SD-101, Leuprolide acetate - Prostatic Neoplasms | Phase 2 | Completed | David Oh | 23 | 2017-05-17 | 2025-12-05 |
| A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy Leuprolide Acetate, Docetaxel, Bicalutamide - Prostate Cancer | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 26 | 2017-02-22 | 2023-02-16 |
| A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study enzalutamide, abiraterone acetate, prednisone - Prostate Cancer | Phase 2 | Active not recruiting | Astellas Pharma Global Development, Inc. | 900 | 2016-12-22 | 2026-10-13 |
Showing 20 of 68. Sign in to see all of them.
Prostatic Neoplasms (48) · Breast Neoplasms (3) · Alzheimer Disease (2) · Neoplasms (2) · Acanthosis Nigricans (1) · Adenocarcinoma (1) · Amenorrhea (1) · Bulimia (1) · Bulimia Nervosa (1) · Carcinoma (1) · Depression, Postpartum (1) · Endocrine System Diseases (1) · Feeding and Eating Disorders (1) · Genital Neoplasms, Male (1) · Granulosa cell tumor of the ovary (1)
M.D. Anderson Cancer Center (7) · National Cancer Institute (NCI) (6) · Mayo Clinic (5) · City of Hope Medical Center (3) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (3) · University of Washington (3) · Dana-Farber Cancer Institute (2) · Fudan University (2) · Voyager Pharmaceutical Corporation (2) · Alliance for Clinical Trials in Oncology (1) · Astellas Pharma Global Development, Inc. (1) · Barbara Ann Karmanos Cancer Institute (1) · Beth Israel Medical Center (1) · Burzynski Research Institute (1) · Camurus AB (1)
United States (57) · Canada (4) · China (4) · Czechia (2) · Finland (2) · South Korea (2) · Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Chile (1) · Denmark (1) · France (1) · Georgia (1)
Christopher Logothetis (2) · Kenneth Pienta, MD (2) · Richard L. Bowen, MD (2) · Alan L Ho (1) · Amar Kishan (1) · Ana M. Aparicio, MD (1) · Angela Smith, M.D. (1) · Anthony V. D'Amico, MD, PhD (1) · Celestia Higano, MD (1) · Charles G. Drake, MD, PhD (1) · Cy A Stein (1) · David C. Smith, MD (1) · David Oh, MD, PhD (1)
PMID 17194907, PMID 18037582, PMID 18291508, PMID 20818327, PMID 22006050, PMID 22282904, PMID 25242417, PMID 25847934, PMID 30811282, PMID 31668850, PMID 33496795, PMID 35780048, PMID 37922910, PMID 38421243, PMID 38494380, PMID 39074346, PMID 39978378, PMID 40907514, PMID 41706486, PMID 42070324, PMID 42574969
P30CA015083 (4), P30CA033572 (2), U10CA032102 (2), 2016 (1), 2023 (1), N01CM00039 (1), N01CM62201 (1), N01CM62202 (1), N01CM62205 (1), N01CM62206 (1), P30CA008748 (1), P30CA015704 (1), P30CA016672 (1), P30CA022453 (1), P30CA138292 (1)